138 related articles for article (PubMed ID: 38215147)
1. Oral manifestations associated with neutropenia in Syrian patients diagnosed with hematological malignancies and undergoing chemotherapy: A cross-sectional study.
Al Beesh FA; Martini N; Suleiman S; Aljoujou A
Medicine (Baltimore); 2024 Jan; 103(2):e36780. PubMed ID: 38215147
[TBL] [Abstract][Full Text] [Related]
2. Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China.
Li Y; Xu W; Jiang Z; Gao Y; Pang Y; Li L; OuYang L; Zhang L; Liu Z; Wang Y; Xiao Y; Huang X
Tumour Biol; 2014 Jun; 35(6):5869-76. PubMed ID: 24664582
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
4. Intensity and duration of neutropenia relates to the development of oral mucositis but not odontogenic infection during chemotherapy for hematological malignancy.
Kishimoto M; Akashi M; Tsuji K; Kusumoto J; Furudoi S; Shibuya Y; Inui Y; Yakushijin K; Kawamoto S; Okamura A; Matsuoka H; Komori T
PLoS One; 2017; 12(7):e0182021. PubMed ID: 28750016
[TBL] [Abstract][Full Text] [Related]
5. [Fever profile of febrile neutropenia in patients treated with cancer chemotherapy for hematological malignancies].
Tamai Y; Imataki O; Kawakami K
Gan To Kagaku Ryoho; 2010 May; 37(5):859-62. PubMed ID: 20495316
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
Kurosawa M; Yonezumi M; Hashino S; Tanaka J; Nishio M; Kaneda M; Ota S; Koda K; Suzuki N; Yoshida M; Hirayama Y; Takimoto R; Torimoto Y; Mori A; Takahashi T; Iizuka S; Ishida T; Kobayashi R; Oda T; Sakai H; Yamamoto S; Takahashi F; Fukuhara T
Int J Hematol; 2012 Dec; 96(6):748-57. PubMed ID: 23111539
[TBL] [Abstract][Full Text] [Related]
7. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
8. A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies.
Moreau M; Klastersky J; Schwarzbold A; Muanza F; Georgala A; Aoun M; Loizidou A; Barette M; Costantini S; Delmelle M; Dubreucq L; Vekemans M; Ferrant A; Bron D; Paesmans M
Ann Oncol; 2009 Mar; 20(3):513-9. PubMed ID: 19139177
[TBL] [Abstract][Full Text] [Related]
9. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
10. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
[TBL] [Abstract][Full Text] [Related]
11. Neutropenic ulcers in oncology: terminology, diagnosis, and management.
Güneri P; Epstein JB; Bolukbasi G; Spielberger RT
Support Care Cancer; 2023 Nov; 31(12):716. PubMed ID: 37991547
[TBL] [Abstract][Full Text] [Related]
12. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
[TBL] [Abstract][Full Text] [Related]
13. INVASIVE FUNGAL INFECTION AMONG FEBRILE PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA IN THAILAND.
Phikulsod P; Suwannawiboon B; Chayakulkeeree M
Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):159-69. PubMed ID: 29644832
[TBL] [Abstract][Full Text] [Related]
14. Treatment of systemic fungal infections in patients with hematologic malignancies.
Böhme A; Karthaus M
Antibiot Chemother (1971); 2000; 50():79-93. PubMed ID: 10874457
[No Abstract] [Full Text] [Related]
15. [Role of daptomycin in the treatment of infections in patients with hematological malignancies].
Salavert M; Calabuig E
Med Clin (Barc); 2010 Dec; 135 Suppl 3():36-47. PubMed ID: 21477703
[TBL] [Abstract][Full Text] [Related]
16. Colchicine mouth washings to improve oral mucositis in patients with hematological malignancies: a clinical trial.
Garavito AA; Cardona AF; Reveiz L; Ospina E; Yepes A; Ospina V
Palliat Support Care; 2008 Dec; 6(4):371-6. PubMed ID: 19006592
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.
Cornely OA; Ullmann AJ; Karthaus M
Blood; 2003 May; 101(9):3365-72. PubMed ID: 12393455
[TBL] [Abstract][Full Text] [Related]
18. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
[TBL] [Abstract][Full Text] [Related]
19. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
Wang L; Wang Y; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Front Med; 2019 Jun; 13(3):365-377. PubMed ID: 30604166
[TBL] [Abstract][Full Text] [Related]
20. Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.
Widmer AF; Kern WV; Roth JA; Dettenkofer M; Goetting T; Bertz H; Theilacker C;
Infection; 2019 Oct; 47(5):837-845. PubMed ID: 31187401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
